Stryker shares tumble despite strong Q2 results and raised guidance
FORT WORTH, Texas—Jennifer Yoss, Vice President of Accounting at CorVel Corp (NASDAQ:CRVL), a $5.7 billion market cap company with a "GREAT" financial health rating according to InvestingPro, executed a series of stock transactions on May 29, 2025. According to a recent SEC filing, Yoss sold 1,050 shares of CorVel’s common stock at an average price of $111.39 per share, amounting to a total of $116,959.
In a related transaction, Yoss exercised options to acquire the same number of shares—1,050—at a price of $39.827 per share. Following these transactions, she holds 2,088 shares directly. The company has shown strong performance with 12.6% revenue growth in the last twelve months.
These transactions were part of a routine financial strategy, and Yoss’s actions reflect a common practice among executives to manage their equity holdings. InvestingPro analysis reveals the stock trades at a high P/E ratio of 61.5, with several additional valuation metrics available in the comprehensive Pro Research Report, which provides deep-dive analysis of CorVel and 1,400+ other US stocks.
In other recent news, CorVel Corp reported its Q4 2025 financial results, showing a 12% increase in revenue to $232 million and a 38% rise in earnings per share to $0.51. Despite these solid figures, the company’s stock saw a decline, possibly indicating investor concerns about future growth prospects. For the fiscal year 2025, CorVel achieved a 13% increase in total revenue, reaching $896 million, and a 24% growth in annual earnings per share to $1.83. The company also highlighted a 24% increase in revenue from its network solutions segment, contributing significantly to its overall performance. CorVel continues to focus on AI integration and operational efficiency as part of its strategic initiatives. Analysts have not issued new upgrades or downgrades, but the company’s financial results reflect robust growth in its core business areas. The firm remains committed to investing in technology and enhancing service offerings to address potential challenges in the healthcare sector. These developments underscore CorVel’s ongoing efforts to navigate a competitive market environment.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.